Cleavage and polyadenylation specificity factor (CPSF)-derived peptides can induce HLA-A2-restricted and tumor-specific CTLs in the majority of gastrointestinal cancer patients (Q28216625)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 20 May 2002)

Language	Label	Description	Also known as
English	Cleavage and polyadenylation specificity factor (CPSF)-derived peptides can induce HLA-A2-restricted and tumor-specific CTLs in the majority of gastrointestinal cancer patients	scientific article (publication date: 20 May 2002)

Statements

scholarly article

0 references

Cleavage and polyadenylation specificity factor (CPSF)-derived peptides can induce HLA-A2-restricted and tumor-specific CTLs in the majority of gastrointestinal cancer patients (English)

0 references

author name string

Yoshiaki Maeda

1

0 references

Masaaki Ito

2

0 references

Nanae Harashima

3

0 references

Tetsuya Nakatsura

4

0 references

Naoya Hida

5

0 references

Nobue Imai

6

0 references

Yuuji Sato

7

0 references

Shigeki Shichijo

8

0 references

Satoru Todo

9

0 references

Kyogo Itoh

10

0 references

language of work or name

0 references

publication date

20 May 2002

0 references

International Journal of Cancer

0 references

99

0 references

3

0 references

409-17

0 references

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Identification of cyclophilin B-derived peptides capable of inducing histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Genetic diversity of HLA-A2: evolutionary and functional significance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

MHC ligands and peptide motifs: first listing

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

The 160-kD subunit of human cleavage-polyadenylation specificity factor coordinates pre-mRNA 3'-end formation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

RNA ligands selected by cleavage stimulation factor contain distinct sequence motifs that function as downstream elements in 3'-end processing of pre-mRNA.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Nuclear domains enriched in RNA 3'-processing factors associate with coiled bodies and histone genes in a cell cycle-dependent manner

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

A subset of poly(A) polymerase is concentrated at sites of RNA synthesis and is associated with domains enriched in splicing factors and poly(A) RNA

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10377

21 January 2018

Identifiers

10.1002/IJC.10377

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28216625&oldid=1360839271"